DE68916777T2 - Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis. - Google Patents
Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis.Info
- Publication number
- DE68916777T2 DE68916777T2 DE68916777T DE68916777T DE68916777T2 DE 68916777 T2 DE68916777 T2 DE 68916777T2 DE 68916777 T DE68916777 T DE 68916777T DE 68916777 T DE68916777 T DE 68916777T DE 68916777 T2 DE68916777 T2 DE 68916777T2
- Authority
- DE
- Germany
- Prior art keywords
- psoriasis
- tnf
- necrosis factor
- tumor necrosis
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 201000004681 Psoriasis Diseases 0.000 abstract 1
- 108060008682 Tumor Necrosis Factor Proteins 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- 239000003085 diluting agent Substances 0.000 abstract 1
- 239000003937 drug carrier Substances 0.000 abstract 1
- 239000000546 pharmaceutical excipient Substances 0.000 abstract 1
- 102000003390 tumor necrosis factor Human genes 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
- A61K38/191—Tumor necrosis factors [TNF], e.g. lymphotoxin [LT], i.e. TNF-beta
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Dermatology (AREA)
- Zoology (AREA)
- Immunology (AREA)
- Gastroenterology & Hepatology (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Peptides Or Proteins (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US29049788A | 1988-12-27 | 1988-12-27 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| DE68916777D1 DE68916777D1 (de) | 1994-08-18 |
| DE68916777T2 true DE68916777T2 (de) | 1995-03-16 |
Family
ID=23116275
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE68916777T Expired - Lifetime DE68916777T2 (de) | 1988-12-27 | 1989-12-04 | Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis. |
Country Status (7)
| Country | Link |
|---|---|
| EP (1) | EP0377823B1 (https=) |
| JP (1) | JPH02209812A (https=) |
| AT (1) | ATE108331T1 (https=) |
| AU (1) | AU633037B2 (https=) |
| CA (1) | CA2003981C (https=) |
| DE (1) | DE68916777T2 (https=) |
| DK (1) | DK658889A (https=) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5190750A (en) * | 1990-03-09 | 1993-03-02 | Asahi Kasei Kogyo Kabushiki Kaisha | Methods for the treatment of demyelinating disease, uveitis, or graft-versus-host disease using tnf |
| US20040220103A1 (en) | 1999-04-19 | 2004-11-04 | Immunex Corporation | Soluble tumor necrosis factor receptor treatment of medical disorders |
| TWI439284B (zh) | 2004-04-09 | 2014-06-01 | 艾伯維生物技術有限責任公司 | 用於治療ＴＮＦα相關失調症之多重可變劑量療法 |
| CN102961746B (zh) | 2005-05-16 | 2016-06-15 | 艾伯维生物技术有限公司 | TNFα抑制剂治疗腐蚀性多关节炎的用途 |
| US9605064B2 (en) | 2006-04-10 | 2017-03-28 | Abbvie Biotechnology Ltd | Methods and compositions for treatment of skin disorders |
| CN106729633A (zh) * | 2017-03-03 | 2017-05-31 | 上海唯科生物制药有限公司 | 一种肿瘤坏死因子直肠给药制剂及其制备方法 |
| CA3202358A1 (en) * | 2020-12-16 | 2022-06-23 | Andreas BOSSHART | Novel slow-release prodrugs |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879226A (en) * | 1984-04-06 | 1989-11-07 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel human physiologically active polypeptide |
| AU2844889A (en) * | 1988-01-22 | 1989-07-27 | Collagen Corporation | Method for suppressing the growth of normal and cancer cells |
-
1989
- 1989-11-27 CA CA002003981A patent/CA2003981C/en not_active Expired - Lifetime
- 1989-12-04 AT AT89122317T patent/ATE108331T1/de not_active IP Right Cessation
- 1989-12-04 DE DE68916777T patent/DE68916777T2/de not_active Expired - Lifetime
- 1989-12-04 EP EP89122317A patent/EP0377823B1/en not_active Expired - Lifetime
- 1989-12-19 AU AU46853/89A patent/AU633037B2/en not_active Ceased
- 1989-12-22 DK DK658889A patent/DK658889A/da not_active Application Discontinuation
- 1989-12-27 JP JP1336408A patent/JPH02209812A/ja active Granted
Also Published As
| Publication number | Publication date |
|---|---|
| AU633037B2 (en) | 1993-01-21 |
| DK658889A (da) | 1990-06-28 |
| DE68916777D1 (de) | 1994-08-18 |
| ATE108331T1 (de) | 1994-07-15 |
| EP0377823B1 (en) | 1994-07-13 |
| AU4685389A (en) | 1990-07-05 |
| JPH0565492B2 (https=) | 1993-09-17 |
| CA2003981C (en) | 2000-06-13 |
| CA2003981A1 (en) | 1990-06-27 |
| DK658889D0 (da) | 1989-12-22 |
| EP0377823A3 (en) | 1991-09-11 |
| JPH02209812A (ja) | 1990-08-21 |
| EP0377823A2 (en) | 1990-07-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US5342613A (en) | Pharmaceutical compositions and use thereof in the treatment of psoriasis | |
| DE69333321T2 (de) | Verwendung eines Consensus-Interferons zur Reduzierung der Nebeneffekte in der Interferon Behandlung von viralen Hepatiten. | |
| DE69434121T2 (de) | Pharmazeutische zusammensetzung zur immunverstärkenden therapie | |
| DE69327788T2 (de) | Pharmazeutische zusammenstezungen zur hemmung von tumoren in verbindung mit prostaten adenokarzinom magenkrebs und brustkrebs | |
| DE69010162T2 (de) | Zusammensetzung zur Behandlung von Entzündung. | |
| DE69432638T2 (de) | Anwendung von HGF zur Herstellung eines Medikaments gegen Zentralnervensystemstörungen | |
| JPS63502985A (ja) | 角膜基質創傷の治療のための組成物 | |
| EP2563370B1 (de) | Verwendung einer phospholipid und glycyrrhizinsäure enthaltenden zusammensetzung zur entfernung von subkutanen fettansammlungen durch subkutane lipolyse | |
| DE69431300T2 (de) | Eine pharmazeutische oder kosmetische zubereitung, die eine kolostrumfraktion enthält und deren medizinische verwendung | |
| EP1133992B1 (en) | Novel pharmacological activities of curcuma longa extracts | |
| EP0295280B1 (en) | Use of protoporphyrin and tin mesoporphyrin for the manufacture of a medicament for the treatment of psoriasis | |
| DE68909100T2 (de) | Physiologisch wirkende Substanzen, Verfahren zu ihrer Herstellung und pharmazeutische Zusammensetzungen davon. | |
| US5028422A (en) | Treatment of basal cell carcinoma intralesionally with recombinant human alpha interferon | |
| DE68916777T2 (de) | Verwendung von TNF zur Herstellung eines Arzneimittels zur Behandlung von Psoriasis. | |
| DE69232596T2 (de) | Inhibitor von nebenwirkungen zur krebstherapy | |
| EP0231819A2 (en) | Pharmaceutical agent for the treatment of myelogenous leukemia | |
| Aly et al. | Topical griseofulvin in the treatment of dermatophytoses | |
| EP0305181B1 (en) | Ethyl-(+)-apovincaminate for treating demyelinization clinical patterns of autoimmune origin | |
| DE3876817T2 (de) | Anwendung des humanblut-koagulationsfaktors-xiii zur behandlung von colitis gravis. | |
| DE3750464T2 (de) | Pharmazeutisches Präparat zur Behandlung des Katarakts. | |
| DE69804466T2 (de) | Robinia pseudoacacia lektin und seine verwendungen | |
| US5514652A (en) | Therapy of respiratory tract diseases using basic fibroblast growth factor | |
| DE102011003478A1 (de) | Antivirales Mittel enthaltend rekombinante Mistellektine | |
| EP0885013B1 (de) | Verwendung von multipotenten paramunitätsinducern aus attenuierten, nicht-immunogenen pockenviren oder parapockenviren zur herstellung von arzneimitteln | |
| JP2681467B2 (ja) | ヒト白血球インターフエロン含有局所用組成物 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| 8364 | No opposition during term of opposition | ||
| 8330 | Complete renunciation |